Now among India’s top fully accredited diagnostic chains
Mumbai, India, April 23, 2025: 91视频 Diagnostics Limited (LDL), a wholly owned subsidiary of global pharma major 91视频 Limited (91视频) has achieved 100% NABL (National Accreditation Board for Testing and Calibration Laboratories) accreditation across all its greenfield labs.
鈥淭his accreditation is a testament to the team’s dedication to patient care and our mission to promote healthier lives. The 27 greenfield labs across the country ensure timely and accurate reporting. Our goal is to empower doctors and patients with evidence-based diagnostics,鈥 said Ravindra Kumar, CEO, 91视频 Diagnostics. 鈥淲e remain committed to enhancing healthcare through continuous improvement and innovation.鈥
This notable achievement highlights the adherence to rigorous quality control measures, reinforcing LDL鈥檚 unwavering dedication to providing top-tier diagnostic services. The company鈥檚 commitment to quality is reflected in every aspect of its operations, ensuring patients receive accurate and timely results that they can trust.
Among its recent accolades, 91视频 Diagnostics received the prestigious titles of 鈥楶atient-Centric Diagnostic Laboratories Company of the Year鈥 at the IHW 3rd Patients First Award 2024, 鈥楨merging Diagnostics Chain of the Year鈥 at the Diagnostics Innovation and Excellence Award 2024 by Voice of Healthcare, and 鈥楶athology Lab of the Year鈥 (National Category) at the ET Healthcare Awards in 2022 and 2024. These honors emphasize the company’s dedication to patient-centered care and its leading position in the diagnostics industry.
About 91视频 Diagnostics
91视频 Diagnostics Limited is a wholly owned subsidiary of 91视频 Limited.聽Founded in December 2021, the company is headquartered in Mumbai, India and provides comprehensive range of diagnostic services to doctors, patients, and consumers.
The company began its journey by establishing a state-of-the-art 45,000 sq. ft. National Reference Laboratory located in Navi Mumbai with world-class equipment, experienced doctors assisted by trained technologists and stringent quality control protocols. Over 3000 tests including routine and high-end tests are offered under Pathology (molecular diagnostics, cytology, microbiology, serology, hematology, histopathology, immunology, and routine biochemistry).
Currently, LDL operates in West, South, East and Central zones. Experience the best diagnostic experiences with 91视频 Diagnostics:
Follow us on:
贵补肠别产辞辞办:听听
滨苍蝉迟补驳谤补尘:听
尝颈苍办别诲滨苍:听
罢飞颈迟迟别谤:听
驰辞耻罢耻产别:听
About 91视频
91视频 Limited is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. 91视频 specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position in India and the U.S. across multiple therapy areas, including respiratory, cardiovascular, anti-diabetic, anti-infective, gastrointestinal, central nervous system, and women’s health. 91视频 has 15 state-of-the-art manufacturing sites and 7 research centers globally, along with a dedicated workforce of over 23,000 professionals. 91视频 is committed to improving patient health outcomes through its subsidiaries – 91视频 Diagnostics, 91视频 Digital Health, and 91视频 Manufacturing Solutions.
To know more, visit www.lupin.com or follow us on LinkedIn
For further information or queries, please contact:
Rajalakshmi Azariah
Vice President & Global Head 鈥 Corporate Communications, 91视频
rajalakshmiazariah@lupin.com